Merck & Co. Inc. buy UBS Group AG
Start price
31.07.24
/
50%
€104.60
Target price
31.07.25
€131.36
Performance (%)
-34.80%
End price
01.08.25
€68.20
Summary
This prediction ended on 01.08.25 with a price of €68.20. Massive losses of -34.80% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.27 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -2.028% | -2.028% | -3.774% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at UBS Group AG from $148.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€93.10
07.01.26
07.01.26
€111.10
07.01.27
07.01.27
-1.40%
19.01.26
19.01.26
Stopped prediction by UBS_Group_AG for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€96.50
08.01.25
08.01.25
€116.45
08.01.26
08.01.26
-1.35%
09.01.26
09.01.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€117.60
02.02.24
02.02.24
€137.06
02.02.25
02.02.25
-18.88%
03.02.25
03.02.25